GSK

GSK, Sanofi, Takeda sign with Singapore partnership to advance biologic manufacturing
Fierce Pharma
Tue, 12/6/22 - 08:54 pm
GSK
Sanofi
Takeda
Singapore
biologics
GSK Notches Phase III Win for Jemperli in Endometrial Cancer
BioSpace
Sun, 12/4/22 - 01:13 pm
GSK
Jemperli
clinical trials
endometrial cancer
GSK unveils Keytruda head-to-head data in lung cancer—and they look good at first glance
Fierce Pharma
Wed, 11/30/22 - 07:58 pm
GSK
Merck
Jemperli
Keytruda
clinical trials
non-small cell lung cancer
GSK survey finds COVID, lack of early HCP conversations hitting lupus patients' care
Fierce Pharma
Tue, 11/29/22 - 08:29 pm
GSK
lupus
Benlysta
patients
COVID-19
pharma marketing
When is big pharma no longer big pharma?
EP Vantage
Sat, 11/26/22 - 07:20 pm
GSK
market cap
Big Pharma
GSK’s “crown jewels” already look tarnished
EP Vantage
Wed, 11/23/22 - 07:27 am
GSK
Blenrep
Emma Walmsley
daprodustat
gepotidacin
otilimab
Jemperli
Zejula
cabotegravir
GSK to pull blood cancer drug from US market after study failure
BioPharma Dive
Tue, 11/22/22 - 11:08 am
GSK
blood cancer
Blenrep
clinical trials
Multiple Myeloma
GSK to slash about 150 consumer commercial jobs in India
Fierce Pharma
Mon, 11/21/22 - 06:35 pm
GSK
India
layoffs
GSK, J&J and AZ top global drug access index, but foundation says plenty more work needs to be done
Fierce Pharma
Thu, 11/17/22 - 12:13 pm
GSK
JNJ
AstraZeneca
Access to Medicine Foundation
drug access
GSK's cell therapy retreat hits another partner as drugmaker exits Immatics collaboration
Endpoints
Thu, 11/17/22 - 10:38 am
GSK
cell therapy
Immatics
GSK Digital & Tech Executive Takes Drug-Hunting Inspiration from Outer Space
MedCity News
Tue, 11/15/22 - 10:50 am
GSK
artificial intelligence
drug discovery
GSK reports positive Phase IIa data for tuberculosis treatment
Clinical Trials Arena
Tue, 11/15/22 - 10:28 am
GSK
clinical trials
GSK3036656
tuberculosis
AstraZeneca and Sanofi win big as Europe's human medicines committee endorses approvals, label expansions
Fierce Pharma
Mon, 11/14/22 - 07:10 pm
Europe
AstraZeneca
Sanofi
COVID-19
cancer
GSK
Regeneron
GSK Restricts the Use of PARP Inhibitor in Ovarian Cancer at the FDA's Request
BioSpace
Sun, 11/13/22 - 07:07 pm
GSK
ovarian cancer
Zejula
PARP inhibitors
FDA
Sanofi, GSK crash the COVID-19 vaccine party late with a world-first nod for their next-gen booster
Fierce Pharma
Thu, 11/10/22 - 10:22 pm
Sanofi
GSK
COVID-19
Europe
vaccines
boosters
GSK plans phase 3 for hepatitis B drug bepirovirsen, despite efficacy drop
Pharmaphorum
Wed, 11/9/22 - 10:49 am
GSK
hepatitis B
bepirovirsen
clinical trials
GSK preps filing for novel antibiotic for urinary tract infections
Pharmaphorum
Mon, 11/7/22 - 10:58 am
GSK
antibiotics
UTIs
gepotidacin
Time for GSK to stop dreaming about Blenrep
EP Vantage
Mon, 11/7/22 - 10:53 am
GSK
BCMA
Blenrep
clinical trials
Multiple Myeloma
After Haleon spinoff, GSK raises forecasts on ‘strong’ Q3
Pharmaphorum
Wed, 11/2/22 - 10:40 am
earnings
GSK
Haleon
Shingrix
With FDA decision penciled in for May, GSK powers ahead in RSV race with Pfizer
Fierce Biotech
Wed, 11/2/22 - 10:25 am
GSK
Pfizer
RSV
vaccines
FDA

Pages